Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma (ACVDL)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
The University of Hong Kong
Information provided by (Responsible Party):
Vejle Hospital
ClinicalTrials.gov Identifier:
NCT01481194
First received: November 21, 2011
Last updated: December 9, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2019
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)